1 Study Coverage 1.1 Vitamin K Antagonists (VKA) Product Introduction 1.2 Global Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028 1.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028 1.3 United States Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028 1.3.1 United States Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028 1.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028 1.4 Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Vitamin K Antagonists (VKA) in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Vitamin K Antagonists (VKA) Market Dynamics 1.5.1 Vitamin K Antagonists (VKA) Industry Trends 1.5.2 Vitamin K Antagonists (VKA) Market Drivers 1.5.3 Vitamin K Antagonists (VKA) Market Challenges 1.5.4 Vitamin K Antagonists (VKA) Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Vitamin K Antagonists (VKA) Market Segment by Type 2.1.1 Oral Vitamin K Antagonists 2.1.2 Injection Vitamin K Antagonists 2.2 Global Vitamin K Antagonists (VKA) Market Size by Type 2.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Vitamin K Antagonists (VKA) Market Size by Type 2.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Vitamin K Antagonists (VKA) Market Segment by Application 3.1.1 VTE 3.1.2 ACS/MI 3.1.3 AF 3.1.4 Others 3.2 Global Vitamin K Antagonists (VKA) Market Size by Application 3.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Vitamin K Antagonists (VKA) Market Size by Application 3.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Vitamin K Antagonists (VKA) Competitor Landscape by Company 4.1 Global Vitamin K Antagonists (VKA) Market Size by Company 4.1.1 Top Global Vitamin K Antagonists (VKA) Manufacturers Ranked by Revenue (2021) 4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturer (2017-2022) 4.1.3 Global Vitamin K Antagonists (VKA) Sales by Manufacturer (2017-2022) 4.1.4 Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022) 4.2 Global Vitamin K Antagonists (VKA) Concentration Ratio (CR) 4.2.1 Vitamin K Antagonists (VKA) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vitamin K Antagonists (VKA) in 2021 4.2.3 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Type 4.3.1 Global Vitamin K Antagonists (VKA) Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Vitamin K Antagonists (VKA) Product Type 4.3.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Vitamin K Antagonists (VKA) Market Size by Company 4.5.1 Top Vitamin K Antagonists (VKA) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Vitamin K Antagonists (VKA) Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Vitamin K Antagonists (VKA) Sales by Players (2020, 2021 & 2022) 5 Global Vitamin K Antagonists (VKA) Market Size by Region 5.1 Global Vitamin K Antagonists (VKA) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Vitamin K Antagonists (VKA) Market Size in Volume by Region (2017-2028) 5.2.1 Global Vitamin K Antagonists (VKA) Sales in Volume by Region: 2017-2022 5.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028) 5.3 Global Vitamin K Antagonists (VKA) Market Size in Value by Region (2017-2028) 5.3.1 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2017-2022 5.3.2 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028 6.1.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028 6.3.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028 6.4.2 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Corporation Information 7.1.2 Sanofi Description and Business Overview 7.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered 7.1.5 Sanofi Recent Development 7.2 Bristol-Myers Squibb 7.2.1 Bristol-Myers Squibb Corporation Information 7.2.2 Bristol-Myers Squibb Description and Business Overview 7.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered 7.2.5 Bristol-Myers Squibb Recent Development 7.3 Bayer 7.3.1 Bayer Corporation Information 7.3.2 Bayer Description and Business Overview 7.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered 7.3.5 Bayer Recent Development 7.4 Johnson & Johnson 7.4.1 Johnson & Johnson Corporation Information 7.4.2 Johnson & Johnson Description and Business Overview 7.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered 7.4.5 Johnson & Johnson Recent Development 7.5 Genentech (Roche) 7.5.1 Genentech (Roche) Corporation Information 7.5.2 Genentech (Roche) Description and Business Overview 7.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered 7.5.5 Genentech (Roche) Recent Development 7.6 Boehringer Ingelheim 7.6.1 Boehringer Ingelheim Corporation Information 7.6.2 Boehringer Ingelheim Description and Business Overview 7.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered 7.6.5 Boehringer Ingelheim Recent Development 7.7 Lilly 7.7.1 Lilly Corporation Information 7.7.2 Lilly Description and Business Overview 7.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered 7.7.5 Lilly Recent Development 7.8 Daiichi Sankyo 7.8.1 Daiichi Sankyo Corporation Information 7.8.2 Daiichi Sankyo Description and Business Overview 7.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered 7.8.5 Daiichi Sankyo Recent Development 7.9 Otsuka 7.9.1 Otsuka Corporation Information 7.9.2 Otsuka Description and Business Overview 7.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered 7.9.5 Otsuka Recent Development 7.10 AstraZeneca 7.10.1 AstraZeneca Corporation Information 7.10.2 AstraZeneca Description and Business Overview 7.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered 7.10.5 AstraZeneca Recent Development 7.11 Pfizer 7.11.1 Pfizer Corporation Information 7.11.2 Pfizer Description and Business Overview 7.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Pfizer Vitamin K Antagonists (VKA) Products Offered 7.11.5 Pfizer Recent Development 7.12 Aspen 7.12.1 Aspen Corporation Information 7.12.2 Aspen Description and Business Overview 7.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Aspen Products Offered 7.12.5 Aspen Recent Development 7.13 The Medicines Company 7.13.1 The Medicines Company Corporation Information 7.13.2 The Medicines Company Description and Business Overview 7.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 7.13.4 The Medicines Company Products Offered 7.13.5 The Medicines Company Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Vitamin K Antagonists (VKA) Industry Chain Analysis 8.2 Vitamin K Antagonists (VKA) Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Vitamin K Antagonists (VKA) Distributors 8.3 Vitamin K Antagonists (VKA) Production Mode & Process 8.4 Vitamin K Antagonists (VKA) Sales and Marketing 8.4.1 Vitamin K Antagonists (VKA) Sales Channels 8.4.2 Vitamin K Antagonists (VKA) Distributors 8.5 Vitamin K Antagonists (VKA) Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Vitamin K Antagonists (VKA) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Vitamin K Antagonists (VKA) Market Trends Table 3. Vitamin K Antagonists (VKA) Market Drivers Table 4. Vitamin K Antagonists (VKA) Market Challenges Table 5. Vitamin K Antagonists (VKA) Market Restraints Table 6. Global Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Vitamin K Antagonists (VKA) Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Vitamin K Antagonists (VKA) Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturer, 2017-2022 Table 13. Global Vitamin K Antagonists (VKA) Sales by Manufacturer, (K MT), 2017-2022 Table 14. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturer, 2017-2022 Table 15. Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022) & (USD/MT) Table 16. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2021) Table 18. Top Players of Vitamin K Antagonists (VKA) in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Vitamin K Antagonists (VKA) Product Type Table 20. Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Vitamin K Antagonists (VKA) Players in United States Market, Ranking by Revenue (2021) Table 23. United States Vitamin K Antagonists (VKA) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Vitamin K Antagonists (VKA) Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Vitamin K Antagonists (VKA) Sales by Players, (K MT), 2020, 2021 & 2022 Table 26. United States Vitamin K Antagonists (VKA) Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2022) & (K MT) Table 29. Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028) & (K MT) Table 30. Global Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Vitamin K Antagonists (VKA) Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT) Table 33. North America Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2028) & (K MT) Table 35. Asia Pacific Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT) Table 37. Europe Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT) Table 39. Latin Americaa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT) Table 41. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Sanofi Corporation Information Table 43. Sanofi Description and Business Overview Table 44. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 45. Sanofi Vitamin K Antagonists (VKA) Product Table 46. Sanofi Recent Development Table 47. Bristol-Myers Squibb Corporation Information Table 48. Bristol-Myers Squibb Description and Business Overview Table 49. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 50. Bristol-Myers Squibb Product Table 51. Bristol-Myers Squibb Recent Development Table 52. Bayer Corporation Information Table 53. Bayer Description and Business Overview Table 54. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 55. Bayer Product Table 56. Bayer Recent Development Table 57. Johnson & Johnson Corporation Information Table 58. Johnson & Johnson Description and Business Overview Table 59. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 60. Johnson & Johnson Product Table 61. Johnson & Johnson Recent Development Table 62. Genentech (Roche) Corporation Information Table 63. Genentech (Roche) Description and Business Overview Table 64. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 65. Genentech (Roche) Product Table 66. Genentech (Roche) Recent Development Table 67. Boehringer Ingelheim Corporation Information Table 68. Boehringer Ingelheim Description and Business Overview Table 69. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 70. Boehringer Ingelheim Product Table 71. Boehringer Ingelheim Recent Development Table 72. Lilly Corporation Information Table 73. Lilly Description and Business Overview Table 74. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 75. Lilly Product Table 76. Lilly Recent Development Table 77. Daiichi Sankyo Corporation Information Table 78. Daiichi Sankyo Description and Business Overview Table 79. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 80. Daiichi Sankyo Product Table 81. Daiichi Sankyo Recent Development Table 82. Otsuka Corporation Information Table 83. Otsuka Description and Business Overview Table 84. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 85. Otsuka Product Table 86. Otsuka Recent Development Table 87. AstraZeneca Corporation Information Table 88. AstraZeneca Description and Business Overview Table 89. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 90. AstraZeneca Product Table 91. AstraZeneca Recent Development Table 92. Pfizer Corporation Information Table 93. Pfizer Description and Business Overview Table 94. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 95. Pfizer Product Table 96. Pfizer Recent Development Table 97. Aspen Corporation Information Table 98. Aspen Description and Business Overview Table 99. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 100. Aspen Product Table 101. Aspen Recent Development Table 102. The Medicines Company Corporation Information Table 103. The Medicines Company Description and Business Overview Table 104. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 105. The Medicines Company Product Table 106. The Medicines Company Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. Vitamin K Antagonists (VKA) Customers List Table 110. Vitamin K Antagonists (VKA) Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Vitamin K Antagonists (VKA) Product Picture Figure 2. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million) Figure 4. Global Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT) Figure 5. United States Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million) Figure 7. United States Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT) Figure 8. United States Vitamin K Antagonists (VKA) Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Vitamin K Antagonists (VKA) Market Share in Global, in Volume (K MT) 2017-2028 Figure 10. Vitamin K Antagonists (VKA) Report Years Considered Figure 11. Product Picture of Oral Vitamin K Antagonists Figure 12. Product Picture of Injection Vitamin K Antagonists Figure 13. Global Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028 Figure 14. Global Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028) Figure 16. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT) Figure 17. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT) Figure 19. United States Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028 Figure 20. United States Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028) Figure 22. United States Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT) Figure 23. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT) Figure 25. Product Picture of VTE Figure 26. Product Picture of ACS/MI Figure 27. Product Picture of AF Figure 28. Product Picture of Others Figure 29. Global Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028 Figure 30. Global Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028) Figure 32. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT) Figure 33. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT) Figure 35. United States Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028 Figure 36. United States Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028) Figure 38. United States Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT) Figure 39. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT) Figure 41. North America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 42. North America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 46. Europe Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 53. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 65. Latin America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 70. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. UAE Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Vitamin K Antagonists (VKA) Value Chain Figure 75. Vitamin K Antagonists (VKA) Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Sanofi Bristol-Myers Squibb Bayer Johnson & Johnson Genentech (Roche) Boehringer Ingelheim Lilly Daiichi Sankyo Otsuka AstraZeneca Pfizer Aspen The Medicines Company